08045804946
Send Inquiry
ZOLTERO 4MG INJ
450.0 INR/Number
Product Details:
- Indication Hypercalcemia of malignancy, prevention of skeletal events in cancers
- Pacakaging (Quantity Per Box) 1 vial per box
- Life Span 24 months from manufacturing date
- Brand Name ZOLTERO 4MG INJ
- Origin of Medicine India
- Salt Composition Zoledronic Acid
- Packaging Type Vial
- Click to View more
X
ZOLTERO 4MG INJ Price And Quantity
- 450.0 INR/Number
- 1 Number
- Must be reconstituted with 5ml sterile water before use
- 4mg/5ml (when reconstituted)
- Hetero Healthcare
- Bisphosphonates
- Schedule H Prescription Drug
- As prescribed by healthcare provider
- Intravenous infusion
- Yes
- Clear, colorless to pale yellow solution
ZOLTERO 4MG INJ Product Specifications
- Treats high blood calcium levels, bone complications of cancer
- Administered intravenously by medical professional
- 24 months from manufacturing date
- 1 vial per box
- Hypercalcemia of malignancy, prevention of skeletal events in cancers
- Vial
- As directed by physician
- Adults
- Parenteral Injection
- Zoledronic Acid 4mg
- Adults with bone metastases, Pagets disease, osteoporosis
- Store below 25C, protect from light
- Antineoplastic agent
- 1 Vial (typically 5 ml after reconstitution)
- Injection
- ZOLTERO 4MG INJ
- India
- Zoledronic Acid
- Must be reconstituted with 5ml sterile water before use
- 4mg/5ml (when reconstituted)
- Hetero Healthcare
- Bisphosphonates
- Schedule H Prescription Drug
- As prescribed by healthcare provider
- Intravenous infusion
- Yes
- Clear, colorless to pale yellow solution
ZOLTERO 4MG INJ Trade Information
- Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, South America, North America, Middle East, Africa, Eastern Europe, Western Europe
- All India
Product Description
Zoltero works by binding to the bone and suppressing the activity of osteoclasts (cells that break down bone tissue), which slows bone breakdown, strengthens bones, and minimizes the risk of fractures.
Specific conditions treated by Zoltero include:
- Osteoporosis: Treatment and prevention of weak, brittle bones, particularly in postmenopausal women and men, or those on long-term steroid therapy.
- Hypercalcemia of malignancy: Lowering abnormally high levels of calcium in the blood caused by certain cancers.
- Paget's disease of bone: A condition where bones are weak, deformed, and easily fractured.
- Cancer-related bone complications: Managing bone damage, lesions, and reducing fracture risk in patients with multiple myeloma or cancer that has spread to the bones (bone metastases).
Precise Administration
ZOLTERO 4MG INJ must be reconstituted with 5ml sterile water to achieve the correct dosage strength before it can be administered. It is intended strictly for intravenous infusion and should only be given under medical supervision. Healthcare professionals ensure safe and accurate delivery to optimize therapeutic benefits and minimize side effects.
Robust Therapeutic Uses
This injection is primarily prescribed for adults who are managing bone metastases, osteoporosis, or Paget's disease, as well as to treat hypercalcemia of malignancy. By targeting bone complications arising from cancer, ZOLTERO 4MG INJ helps prevent skeletal events such as fractures, improving overall patient outcomes.
Safe Handling and Storage
Store ZOLTERO 4MG INJ below 25C and protect from light to maintain product stability and effectiveness. Each vial is for single use and should be discarded after administration. The shelf life is 24 months from the manufacturing date, and the medicine should only be handled by trained professionals.
FAQ's of ZOLTERO 4MG INJ:
Q: How is ZOLTERO 4MG INJ administered to patients?
A: ZOLTERO 4MG INJ is administered intravenously by a healthcare professional after it has been reconstituted with 5ml of sterile water for injection. It should never be self-injected.Q: What conditions does ZOLTERO 4MG INJ treat?
A: This medication is indicated for adults with bone metastases, Paget's disease, osteoporosis, and cases of hypercalcemia of malignancy. It also helps in the prevention of skeletal complications caused by cancer.Q: When should ZOLTERO 4MG INJ be used?
A: ZOLTERO 4MG INJ is used when prescribed by a physician for adults needing management of bone disease related to cancer, hypercalcemia, Paget's disease, or osteoporosis. Dosage and frequency are determined based on individual patient needs.Q: What is the reconstitution process for ZOLTERO 4MG INJ?
A: Before administration, each vial must be reconstituted with 5ml of sterile water to form a clear, colorless to pale yellow solution. Only a medical professional should prepare and administer the injection.Q: Where should ZOLTERO 4MG INJ be stored?
A: The vials should be stored below 25C and protected from light. Keep out of reach of children and do not use after the expiry date indicated on the vial.Q: What are the benefits of using ZOLTERO 4MG INJ?
A: ZOLTERO 4MG INJ helps control calcium levels in the blood, reduces bone complications in cancers with bone involvement, and supports bone health in conditions like osteoporosis and Paget's disease, improving patient quality of life.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
